INTERACTION OF AMIODARONE WITH RACEMIC WARFARIN AND ITS SEPARATED ENANTIOMORPHS IN HUMANS

被引：88

作者：

OREILLY, RA

TRAGER, WF

RETTIE, AE

GOULART, DA

机构：

[1] STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA

[2] INST MED RES, SAN JOSE, CA 95128 USA

[3] UNIV WASHINGTON HOSP, SCH PHARM, DEPT MED CHEM, SEATTLE, WA 98105 USA

[4] UNIV WASHINGTON HOSP, SCH PHARM, DEPT PHARMACEUT, SEATTLE, WA 98105 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 42卷 / 03期

关键词：

D O I：

10.1038/clpt.1987.149

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：290 / 294

页数：5

共 20 条

[1] MECHANISM OF WARFARIN POTENTIATION BY AMIODARONE - DOSE-DEPENDENT AND CONCENTRATION-DEPENDENT INHIBITION OF WARFARIN ELIMINATION [J].

ALMOG, S ;

SHAFRAN, N ;

HALKIN, H ;

WEISS, P ;

FARFEL, Z ;

MARTINOWITZ, U ;

BANK, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) :257-261

[2]

DARCY PF, 1980, PHARM INT, V1, P72

[3]

DIAMOND S, 1959, INFORMATION ERROR IN, P104

[4] THE POTENTIATION OF WARFARIN ANTICOAGULATION BY AMIODARONE [J].

HAMER, A ;

PETER, T ;

MANDEL, WJ ;

SCHEINMAN, MM ;

WEISS, D .

CIRCULATION, 1982, 65 (05) :1025-1029

[5] SIDE-EFFECTS OF LONG-TERM AMIODARONE THERAPY [J].

HARRIS, L ;

MCKENNA, WJ ;

ROWLAND, E ;

HOLT, DW ;

STOREY, GCA ;

KRIKLER, DM .

CIRCULATION, 1983, 67 (01) :45-51

[6] WARFARIN - STEREOCHEMICAL ASPECTS OF ITS METABOLISM AND INTERACTION WITH PHENYLBUTAZONE [J].

LEWIS, RJ ;

TRAGER, WF ;

CHAN, KK ;

BRECKENRIDGE, A ;

ORME, M ;

ROLAND, M ;

SCHARY, W .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (06) :1607-1617

[7]

MARTINOWITZ U, 1981, NEW ENGL J MED, V304, P671

[8] INTERACTION OF SODIUM WARFARIN AND DISULFIRAM (ANTABUSE) IN MAN [J].

OREILLY, RA .

ANNALS OF INTERNAL MEDICINE, 1973, 78 (01) :73-76

[9]

OREILLY RA, 1974, CLIN PHARMACOL THER, V16, P348

[10] TICRYNAFEN RACEMIC WARFARIN INTERACTION - HEPATOTOXIC OR STEREOSELECTIVE [J].

OREILLY, RA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :356-361

← 1 2 →